Page last updated: 2024-10-18

indoleacetic acid and Metabolic Syndrome

indoleacetic acid has been researched along with Metabolic Syndrome in 1 studies

indoleacetic acid: RN given refers to unlabeled parent cpd; structure in Merck Index, 9th ed, #4841
auxin : Any of a group of compounds, both naturally occurring and synthetic, that induce cell elongation in plant stems (from Greek alphaupsilonxialphanuomega, "to grow").
indole-3-acetic acid : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PICCHIOTTI, R1
ROCCHI, V1
BELLONI, C1

Other Studies

1 other study available for indoleacetic acid and Metabolic Syndrome

ArticleYear
[SOME CONSIDERATIONS ON INTESTINAL CARCINOIDS AND ON THEIR ENDOCRINO-METABOLIC SYNDROME].
    Il Progresso medico, 1963, Aug-31, Volume: 19

    Topics: Carcinoid Tumor; Humans; Indoleacetic Acids; Intestinal Neoplasms; Malignant Carcinoid Syndrome; Met

1963